ELAN

Elanco Animal Health Incorporated NYSE

Healthcare ·Drug Manufacturers - Specialty & Generic ·US · elanco.com

$22.51

Mkt Cap $11.2B

52w Low $9.42 71.5% of range 52w High $27.72

50d MA $23.84 200d MA $21.50

P/E (TTM) -47.9x

EV/EBITDA 21.8x

P/B 1.7x

Debt/Equity 0.6x

ROE -3.5%

P/FCF 39.6x

RSI (14) —

ATR (14) —

Beta 1.88

50d MA $23.84

200d MA $21.50

Avg Volume 5.0M

About

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear in…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 24, 2026	AMC	0.11	0.13	+18.2%	26.38	+0.7%	+1.7%	-0.7%	+0.1%	-1.1%	-5.7%	—
Nov 5, 2025	AMC	0.13	0.19	+46.2%	21.60	+0.6%	-0.4%	-0.5%	+3.1%	+5.8%	+2.1%	—
Aug 7, 2025	AMC	0.20	0.26	+30.0%	16.48	+0.3%	+1.2%	+3.8%	+5.8%	+8.1%	+9.2%	—
May 7, 2025	AMC	0.31	0.37	+19.4%	12.01	+0.6%	+2.2%	-0.4%	+6.7%	+8.4%	+7.2%	—
Feb 25, 2025	AMC	0.16	0.14	-12.5%	10.70	+1.5%	+4.0%	+2.1%	+4.4%	+5.7%	+0.9%	—
Nov 7, 2024	AMC	0.12	0.13	+8.3%	14.50	-1.5%	-3.0%	-1.6%	-2.6%	-2.1%	-3.2%	—
Aug 8, 2024	AMC	0.24	0.30	+25.0%	12.99	-0.6%	+0.4%	+0.8%	+7.3%	+8.4%	+12.2%	—
May 8, 2024	AMC	0.27	0.34	+24.1%	16.89	-0.4%	+1.8%	+0.7%	+0.7%	+1.1%	+0.9%	—
Feb 26, 2024	AMC	0.10	0.08	-20.0%	16.26	+1.8%	+1.2%	-2.0%	-2.3%	-1.4%	-0.6%	—
Nov 7, 2023	AMC	0.12	0.18	+50.0%	10.70	+0.0%	+1.4%	-4.1%	-0.2%	-1.4%	+6.0%	—
Aug 7, 2023	AMC	0.05	0.18	+260.0%	12.12	+0.2%	+2.8%	+1.2%	+0.8%	+0.4%	-1.0%	—
May 9, 2023	AMC	0.29	0.45	+55.2%	9.31	+1.4%	-3.3%	-5.6%	-7.9%	-4.4%	-8.3%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 25	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$26.38	$26.56	+0.7%	+1.7%	-0.7%	+0.1%	-1.1%	-5.7%
Feb 25	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$26.38	$26.56	+0.7%	+1.7%	-0.7%	+0.1%	-1.1%	-5.7%
Feb 24	Leerink Partners	Maintains	Outperform → Outperform	—	$24.75	$24.06	-2.8%	+6.6%	+8.4%	+5.8%	+6.7%	+5.4%
Feb 19	JP Morgan	Maintains	Overweight → Overweight	—	$24.78	$25.04	+1.0%	+1.7%	+0.8%	-0.1%	+6.5%	+8.3%
Jan 22	Piper Sandler	Upgrade	Neutral → Overweight	—	$24.30	$25.21	+3.7%	+2.5%	+0.4%	+1.6%	+1.3%	-0.7%
Dec 18	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$22.08	$22.30	+1.0%	+0.0%	+1.0%	+1.0%	+0.6%	+1.4%
Nov 6	UBS	Maintains	Buy → Buy	—	$21.60	$21.74	+0.6%	-0.4%	-0.5%	+3.1%	+5.8%	+2.1%
Oct 20	UBS	Maintains	Buy → Buy	—	$21.42	$21.59	+0.8%	+1.4%	+0.9%	+1.0%	+1.6%	+2.9%
Oct 7	JP Morgan	Upgrade	Neutral → Overweight	—	$20.66	$21.12	+2.2%	-1.0%	-1.5%	-2.9%	-4.4%	-3.0%
Sep 24	Stifel	Maintains	Buy → Buy	—	$18.54	$19.11	+3.1%	+1.1%	+2.0%	+5.8%	+5.8%	+8.6%
Aug 11	Piper Sandler	Maintains	Neutral → Neutral	—	$16.67	$17.00	+2.0%	+2.6%	+4.6%	+6.8%	+8.0%	+7.7%
Aug 8	UBS	Maintains	Buy → Buy	—	$16.48	$16.53	+0.3%	+1.2%	+3.8%	+5.8%	+8.1%	+9.2%
Jul 23	UBS	Maintains	Buy → Buy	—	$14.93	$15.12	+1.3%	+0.6%	-1.6%	-0.1%	-2.3%	-3.6%
Jul 17	Leerink Partners	Upgrade	Market Perform → Outperform	—	$14.51	$14.95	+3.0%	+3.1%	+1.9%	+1.2%	+2.9%	+3.5%
Jul 2	Stifel	Maintains	Buy → Buy	—	$14.43	$14.66	+1.6%	+2.0%	+1.5%	+0.3%	+2.2%	+2.4%
Jun 26	William Blair	Upgrade	Market Perform → Outperform	—	$13.76	$14.21	+3.3%	+3.9%	+3.9%	+3.8%	+4.9%	+7.0%
May 19	Stifel	Maintains	Buy → Buy	—	$12.92	$12.74	-1.4%	+2.3%	+1.2%	-2.3%	-1.9%	-2.0%
May 8	Stifel	Maintains	Buy → Buy	—	$12.01	$12.08	+0.6%	+2.2%	-0.4%	+6.7%	+8.4%	+7.2%
Apr 14	Stifel	Maintains	Buy → Buy	—	$8.62	$8.82	+2.3%	+0.7%	-4.4%	-6.0%	-2.1%	-1.6%
Mar 6	Piper Sandler	Maintains	Neutral → Neutral	—	$10.85	$10.68	-1.6%	-0.2%	+2.7%	-0.5%	-7.5%	-4.2%
Feb 26	Barclays	Maintains	Overweight → Overweight	—	$10.70	$10.86	+1.5%	+4.0%	+2.1%	+4.4%	+5.7%	+0.9%
Feb 26	UBS	Maintains	Buy → Buy	—	$10.70	$10.86	+1.5%	+4.0%	+2.1%	+4.4%	+5.7%	+0.9%
Feb 26	Stifel	Maintains	Buy → Buy	—	$10.70	$10.86	+1.5%	+4.0%	+2.1%	+4.4%	+5.7%	+0.9%
Feb 26	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$10.70	$10.86	+1.5%	+4.0%	+2.1%	+4.4%	+5.7%	+0.9%
Feb 21	Stifel	Maintains	Buy → Buy	—	$11.13	$11.19	+0.5%	-1.0%	-0.2%	-3.9%	+0.0%	-1.9%
Jan 29	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$12.17	$12.14	-0.2%	+1.0%	+2.5%	-1.2%	-3.7%	-5.4%
Jan 7	Stifel	Maintains	Buy → Buy	—	$11.92	$11.89	-0.3%	-1.0%	-3.1%	-4.1%	-1.8%	-1.8%
Nov 8	Barclays	Maintains	Overweight → Overweight	—	$14.50	$14.28	-1.5%	-3.0%	-1.6%	-2.6%	-2.1%	-3.2%
Oct 28	Barclays	Maintains	Overweight → Overweight	—	$12.41	$12.49	+0.6%	+0.8%	+0.8%	+3.0%	+1.9%	+1.5%
Sep 23	Barclays	Maintains	Overweight → Overweight	—	$14.07	$14.17	+0.7%	+2.6%	-1.4%	-2.9%	-2.4%	+1.8%
Sep 19	Stifel	Maintains	Buy → Buy	—	$14.65	$14.34	-2.1%	+2.9%	-4.0%	-1.4%	-5.3%	-6.8%
Sep 19	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$14.65	$14.34	-2.1%	+2.9%	-4.0%	-1.4%	-5.3%	-6.8%
Jul 1	Piper Sandler	Maintains	Neutral → Neutral	—	$14.43	$14.46	+0.2%	-2.3%	-2.9%	-2.1%	-1.5%	-3.4%
Jun 28	Barclays	Maintains	Overweight → Overweight	—	$14.27	$14.25	-0.1%	+1.1%	-1.2%	-1.8%	-1.0%	-0.4%
May 13	Piper Sandler	Maintains	Neutral → Neutral	—	$17.00	$17.21	+1.2%	+0.0%	+0.4%	+0.2%	-0.1%	+1.1%
May 9	Barclays	Maintains	Overweight → Overweight	—	$16.89	$16.82	-0.4%	+1.8%	+0.7%	+0.7%	+1.1%	+0.9%
Mar 12	Piper Sandler	Maintains	Neutral → Neutral	—	$16.02	$16.09	+0.4%	-1.6%	-0.7%	-1.7%	-1.9%	-1.5%
Feb 27	Barclays	Maintains	Overweight → Overweight	—	$16.26	$16.56	+1.8%	+1.2%	-2.0%	-2.3%	-1.4%	-0.6%
Feb 27	Morgan Stanley	Maintains	Overweight → Overweight	—	$16.26	$16.56	+1.8%	+1.2%	-2.0%	-2.3%	-1.4%	-0.6%
Feb 27	Goldman Sachs	Maintains	Sell → Sell	—	$16.26	$16.56	+1.8%	+1.2%	-2.0%	-2.3%	-1.4%	-0.6%
Jan 17	Goldman Sachs	Maintains	Sell → Sell	—	$15.13	$14.90	-1.5%	-2.2%	-2.2%	-3.5%	-3.9%	-2.7%
Jan 5	Stifel	Upgrade	Hold → Buy	—	$14.55	$15.46	+6.3%	+6.2%	+6.9%	+5.9%	+4.5%	+6.5%
Dec 15	Morgan Stanley	Upgrade	Equal Weight → Overweight	—	$13.77	$14.06	+2.1%	-0.1%	-0.7%	+3.8%	+1.7%	+5.4%
Dec 7	Stifel	Maintains	Hold → Hold	—	$12.87	$13.06	+1.5%	-0.8%	-0.5%	-1.2%	-1.4%	+6.1%
Nov 13	Piper Sandler	Maintains	Neutral → Neutral	—	$10.68	$10.68	+0.0%	-1.2%	+6.2%	+6.8%	+7.6%	+10.7%
Nov 8	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$10.70	$10.70	+0.0%	+1.4%	-4.1%	-0.2%	-1.4%	+6.0%
Oct 30	Stifel	Maintains	Hold → Hold	—	$8.85	$8.89	+0.5%	-0.5%	-0.5%	-2.5%	+5.9%	+8.6%
Aug 14	Piper Sandler	Maintains	Neutral → Neutral	—	$12.17	$12.12	-0.4%	-1.4%	-3.3%	-5.2%	-5.8%	-4.5%
Aug 9	Goldman Sachs	Maintains	Sell → Sell	—	$12.46	$12.45	-0.1%	-1.5%	-1.9%	-2.3%	-3.7%	-5.5%
Aug 8	Goldman Sachs	Maintains	Sell → Sell	—	$12.12	$12.15	+0.2%	+2.8%	+1.2%	+0.8%	+0.4%	-1.0%

Recent Filings

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

Abbott Laboratories' appointment of a new executive effective April 1, 2026, signals potential strategic shifts in operations or leadership direction that could affect near-term stock performance and investor confidence in company management.

Mar 18

8-K

Elanco Animal Health Incorporated -- 8-K Filing

Elanco Animal Health achieved 9% organic constant currency revenue growth in Q4, marking its 10th consecutive quarter of underlying growth, signaling strong execution of its growth and innovation strategy.

Feb 24

Data updated apr 25, 2026 6:49am · Source: massive.com